0 NASDAQ Companies - June 17, 2019Aclaris Therapeutics Announces Positive 6-Month Results from a Phase 2 Open-Label Clinical Trial of ATI-502 Topical in Patients with Androgenetic Alopecia (Male/Female Pattern-Baldness)Read More
0 NASDAQ Companies - June 17, 2019TowerJazz Expands its Leading-Edge High Voltage Low RDSON Power PlatformRead More
0 NASDAQ Companies - June 17, 2019Calithera Achieves Positive Topline Results in Randomized Phase 2 ENTRATA Study of Telaglenastat with Everolimus in Renal Cell CarcinomaRead More
0 NASDAQ Companies - June 17, 2019Ultra Petroleum Corp. Announces Extension of Early Participation Date and Withdrawal Deadline for Exchange Offer for 7.125% Senior Notes due 2025Read More
0 NASDAQ Companies - June 17, 2019VBI Vaccines Announces Positive Top-Line Results from PROTECT, a Pivotal Phase 3 Study of Sci-B-Vac®Read More
0 Canadian Stock Exchange News - June 17, 2019EnviroLeach Announces Addition to the Executive TeamRead More
